MiCells accepts a limited number of clients and partners each year.
All enquiries are treated with discretion.
MiCells provides a sophisticated framework for the long-term cryogenic preservation and global mobilization of autologous blood assets. We ensure absolute biological certainty through a secure chain-of-custody,
Autologous blood storage reduces risks associated with donor incompatibility, supply constraints, and emergency uncertainty.
Using a client’s own blood eliminates immunological mismatch and supports predictable transfusion outcomes when clinically appropriate.
MiCells operates under the guidance of an independent Medical Advisory Board, ensuring alignment with evolving clinical standards, ethics, and best practices.
MiCells is designed to operate within applicable medical, transport, and bio-storage regulations, with jurisdiction-specific compliance frameworks as the platform expands internationally.
The MiCells platform is governed by a distinguished Medical Advisory Board comprising senior professionals across the fields of transfusion medicine, clinical practice, and regulatory compliance. Our experts ensure that every stage of the preservation process—from initial collection to cryogenic stewardship—adheres to the most rigorous international clinical standards and ethical frameworks.
